Hematologic complications of rheumatic disease therapies

被引：7
作者：
George, CS [1 ]
Lichtin, AE [1 ]
机构：
[1] CLEVELAND CLIN FDN, DEPT HEMATOL & MED ONCOL, CLEVELAND, OH 44195 USA
来源：
RHEUMATIC DISEASE CLINICS OF NORTH AMERICA | 1997年 / 23卷 / 02期
关键词：
D O I：
10.1016/S0889-857X(05)70338-0
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Rheumatic disease therapies have expanded to include many cytotoxic and immunosuppressive agents in addition to corticosteroids and nonsteroidal anti-inflammatory drugs. The use of more aggressive therapeutic interventions may expose patients to potential Life-threatening toxicities. This article reviews the potential cytopenias and malignant hematologic neoplasms associated with the use of some of these therapies. The use of recombinant growth factors is also discussed.
引用
收藏
页码：425 / +
页数：1
相关论文
共 82 条
[1]   GOLD INDUCED THROMBOCYTOPENIA - 12 CASES AND A REVIEW OF THE LITERATURE [J].
ADACHI, JD ;
BENSEN, WG ;
KASSAM, Y ;
POWERS, PJ ;
BIANCHI, FA ;
CIVIDINO, A ;
KEAN, WF ;
ROONEY, PJ ;
CRAIG, GL ;
BUCHANAN, WW ;
TUGWELL, PX ;
GORDON, DA ;
LUCARELLI, A ;
SINGAL, DP .
SEMINARS IN ARTHRITIS AND RHEUMATISM, 1987, 16 (04) :287-293
[2]  
ALAWADHI A, 1993, J RHEUMATOL, V20, P1121
[3]  
[Anonymous], 1996, J CLIN ONCOL, V14, P1957
[4]  
ANSTEY A, 1992, J ROY SOC MED, V85, P752
[5]   TREATMENT OF THERAPY-RELATED ACUTE MYELOGENOUS LEUKEMIA AND MYELODYSPLASTIC SYNDROMES [J].
BALLEN, KK ;
ANTIN, JH .
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 1993, 7 (02) :477-493
[6]  
BEUTLER E, 1993, BLOOD, V81, P1411
[7]  
BUCKLEY LM, 1990, J RHEUMATOL, V17, P1158
[8]   ACUTE MYELOGENOUS LEUKEMIA IN A RHEUMATOID-ARTHRITIS PATIENT UNDER CYCLOSPORINE-A THERAPY [J].
CASOLI, P .
CLINICAL RHEUMATOLOGY, 1994, 13 (04) :646-647
[9]  
COLLINS DA, 1993, BRIT J RHEUMATOL, V32, P518
[10]   BONE-MARROW TOXICITY CAUSED BY AZATHIOPRINE IN INFLAMMATORY BOWEL-DISEASE - 27 YEARS OF EXPERIENCE [J].
CONNELL, WR ;
KAMM, MA ;
RITCHIE, JK ;
LENNARDJONES, JE .
GUT, 1993, 34 (08) :1081-1085
123456789